This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2022 Dec;35(12):e15971.

doi: 10.1111/dth.15971. Epub 2022 Nov 16.

More than a genital psoriasis

Riccardo Balestri¹, Giulia Rech¹, Carlo Rene Girardelli¹, Michela Magnano¹

Affiliations

PMID: 36346033
DOI: 10.1111/dth.15971

Comment

More than a genital psoriasis

Riccardo Balestri et al. Dermatol Ther. 2022 Dec.

. 2022 Dec;35(12):e15971.

doi: 10.1111/dth.15971. Epub 2022 Nov 16.

Authors

Riccardo Balestri¹, Giulia Rech¹, Carlo Rene Girardelli¹, Michela Magnano¹

Affiliation

¹ Division of Dermatology, Psoriasis Outpatient Service, Trento, Italy.

PMID: 36346033
DOI: 10.1111/dth.15971

No abstract available

PubMed Disclaimer

Comment on

Exclusively genital psoriasis successfully treated with Risankizumab.
Ceccarelli G, Simonacci M. Ceccarelli G, et al. Dermatol Ther. 2022 Aug;35(8):e15591. doi: 10.1111/dth.15591. Epub 2022 Jun 6. Dermatol Ther. 2022. PMID: 35598296 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Medical
- MedlinePlus Health Information